Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: Appl ... more
Applera and Bio-Rad Enter Settlement Discussions over Patent Infringement Lawsuit
Applera Corporation and Bio-Rad Laboratories announced both parties are conducting settlement discussions concerning the patent infringement lawsuit brought by Applera and Roche Molecular Systems (Roche) against MJ Research in the U.S. District Court for the District of Connecticut. The goal of these discussions is a resolution of all outstanding disputes in the U.S. between the two companies.
Applera Corporation and Roche Molecular Systems originally filed this patent infringement lawsuit in June 1998 against MJ Research relating to certain PCR patents owned by Applera and Roche, and a jury decided in favor of Applera and Roche in 2004. The Court also issued a permanent injunction in September 2005 prohibiting Bio-Rad, as the successor of MJ Research, from manufacturing, selling or servicing infringing thermal cycler products in the U.S. Various post-trial motions remain pending in the case.
No further details of the discussions have yet been made public.
- patent infringement…
- Bio-Rad Laboratories
Applera and BIOTECON Diagnostics (BCD) announced a non-exclusive, worldwide license agreement relating to PCR technology for Food Testing Applications and Genetically-Modified Organism (GMO) Testing Applications: BIOTECON Diagnostics has acquired important rights with the PCR licence. In ... more
Lab21 announced that it has obtained a licence from Celera, an Applera Corporation business, to provide access to its test for cirrhosis risk in patients with chronic hepatitis C viral (HCV) infection in the UK and Ireland. The test, known as CRS7, is the first clinical test capable of pre ... more
A collaboration between Malvern Instruments and Bio-Radhas delivered new analytical tools for the rapid identification of unknown particles. New software to support Malvern’s Morphologi G3-ID, which analyzes particle size, shape and chemical composition, enables the direct comparison of mea ... more
Alnylam Pharmaceuticals, Inc. announced today that it has granted Bio-Rad a non-exclusive license to provide RNAi research products under the Kreutzer-Limmer patent family. This patent family, owned exclusively by Alnylam, covers small interfering RNAs (siRNAs) and their use to mediate RNAi ... more
Applied Biosystems, an Applera Corporation business, and Bio-Rad Laboratories, Inc. announced that they have entered into a settlement agreement resolving the patent infringement lawsuit originally filed by Applera and Roche Molecular Systems against MJ Research (acquired by Bio-Rad in 2004 ... more
- 1New NMR method enables monitoring of chemical reactions in metal containers
- 2Deep learning enables early detection and classification of live bacteria using holography
- 3Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement
- 4analytica 2020: Great exhibitor resonance for the autumnal fair
- 5Formation of quadruple helix DNA tracked in live human cells for the first time
- 6Microplastics transport metallic pollutants
- 7Merck acquires a French company
- 8Hurdle of microscopy overcome
- 9How smart, ultrathin nanosheets go fishing for proteins
- 10The genetic basis of bats’ superpowers revealed